S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 688621 › Research report
← 688621 page
XStocksXray
Market X-Ray report · 19 October 2026

Beijing Sun Novo Pharmaceutical Research Co Ltd (688621)

Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026

Key indicators

Last closeCNY 60.78
52-week range46.51 – 80.40
Return, 1 month / 3 months−12.7% / +19.9%
Return, 1 year / 3 years−14.3% / +2.7%
TrendBelow its 200-day average
RSI (14)30
Volatility (1 year)49.7%
Worst drawdown (1 year)-38.7%
Average daily value traded199.86M CNY
Dividend yield0.3%

Market X-Ray price-based

66/ 100 · High confidence · ahead of 80% of stocks on this exchange
Trend84
Momentum74
Risk (lower is better)52
Liquidity62
Income44

Five-year price chart navy: price · brown: 200-day average

23.9347.7171.4995.271192021-102023-012024-042025-072026-10

Summary

Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) trades on the Shanghai Stock Exchange in China. It last closed at CNY 60.78 on 19 October 2026.

Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 451 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 14.3% and over the last three months it rose 19.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621)

The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange

Lens and metricValueScoreReading
Trend84 · StrongTrading above its long-term averages and near its highs.
Above 200-day average-3.1%
From 52-week high-22.1%
Momentum74 · StrongRising faster than most stocks on this exchange.
3-month return19.9%
6-month return-8.3%
12-month return, skipping the last month-1.8%
Risk (lower is better)52 · FairTypical risk for this exchange.
Volatility (1 year)49.7%
Worst drawdown (1 year)-38.7%
Liquidity62 · FairModerate trading activity.
Average daily value traded199.86M CNY
Zero-volume days0.0%
Income44 · WeakDividend is small or irregular.
Dividend yield0.3%
Years with dividends5

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week−9.2%
1 month−12.7%
3 months+19.9%
6 months−8.3%
1 year−14.3%
3 years+2.7%
5 years–

Signals

50-day / 200-day average67.57 / 62.72
Golden / death cross (60 days)Golden, 18 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.67

Technical summary

DailyBearish5 bullish · 0 neutral · 11 bearish
WeeklyNeutral5 bullish · 1 neutral · 6 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

Recent dividends

Ex-dividend dateAmount per share
29 Jun 2026CNY 0.1870
11 Jun 2025CNY 0.1630
9 Jul 2024CNY 0.1650
12 May 2023CNY 0.8400
15 Apr 2022CNY 0.2650

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 19 Oct 2026